[-] Show simple item record

dc.contributor.authorNelson, Carrieeng
dc.contributor.authorHitchcock, Kristineng
dc.contributor.authorBohlen, James A.eng
dc.date.issued2009-12eng
dc.description.abstractNo studies directly compare low-density lipoprotein (LDL) levels <70 mg/dL to levels of 71 to 100 mg/dL in very-high-risk patients. However, no evidence suggests a “floor” for LDL cholesterol levels beyond which further reductions of heart disease risk can't be achieved (strength of recommendation [SOR]: A, systematic reviews of randomized controlled trials [RCTs]). The target LDL cholesterol of <70 mg/dL is based on data extrapolated from RCTs (SOR: B).eng
dc.identifier.citationJournal of Family Practice, 58(12) 2009: 665-667.eng
dc.identifier.urihttp://hdl.handle.net/10355/4005eng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofClinical Inquiries, 2009 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.subjectcoronary artery diseaseeng
dc.subjectstatin therapyeng
dc.subjectcholesteroleng
dc.subject.lcshCoronary heart disease -- Preventioneng
dc.subject.lcshLow density lipoproteinseng
dc.subject.lcshStatins (Cardiovascular agents) -- Effectivenesseng
dc.titleWhat does the evidence tell us about treating very-high-risk patients to an LDL <70 mg/dL?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record